The degree of variation we observed for dialysis was similar to that found in more consensus-driven practices, such as the prescription of renin-angiotensin-aldosterone system blockers for adults with CKD and diabetes.18 On the other hand, it is striking that the use of a life-sustaining treatment varies to a similar extent as the use of preventive treatments. Here, REN is linked to diabetes mellitus.